side effects of glp 1 drugs for weight loss Managing GLP-1 Receptor Agonists – Transformation Control Ozempic and GLP-1 Drugs: Risk

Saxenda contains the active ingredient liraglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist

especially since the intrinsic hypoglycaemia risk of DPP-4 inhibitors is very low

This is the phase 2 trial of retatrutide in individuals with obesity (without type 2 diabetes) in which much of the discussion of this review is focused

In addition to effects on weight and blood glucose control, early laboratory studies in mice suggest that GLP-1 RAs might work through additional biological mechanisms ( 10 , 11 )

Another variable that is difficult to predict is the degree to which GLP - 1 drug users will stay on the medications over an extended period, or even cycle on and off them

Patients can also message the care team through the portal whenever a question or dose-adjustment need comes up